Reuters logo
BRIEF-Aldeyra Therapeutics says results of late stage trial expected in H2 2018
April 27, 2017 / 12:13 PM / 5 months ago

BRIEF-Aldeyra Therapeutics says results of late stage trial expected in H2 2018

April 27 (Reuters) - Aldeyra Therapeutics Inc

* Aldeyra therapeutics announces first patient enrolled in noninfectious anterior uveitis phase 3 clinical trial

* Aldeyra therapeutics inc- results of phase 3 trial are expected in second half of 2018 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below